Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Aroa Biosurgery shares have surged on the back of full-year results that exceeded guidance and restored the company to ...

BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data from select pipeline candidates across the Company’s diversified oncology portfolio at the American Society of ...

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

A hand hygiene intervention, which encouraged patients and visitors to the participating units to perform audits of health ...

BriaCell’s Phase 2 study also achieved a Clinical Benefit Rate (CBR) of 61%, outperforming ASCENT (40%) and TROPiCS-02 (34%), and an Objective Response Rate (ORR) of 14%, which matched or exceeded the ...

Verismo Therapeutics, a clinical-stage CAR T company pioneering the KIR-CAR platform, today provided additional details on ...

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting is scheduled to take place in Chicago, Illinois, USA from May 30 to June 3. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990 ...

The deadline to submit abstracts for scientific posters for the IAEA’s International Conference ... The latest research shows that about 4.2 billion medical radiological examinations are performed ...

To submit your poster abstract, visit alfc2025.com. About the Advanced Lateral Flow Conference The Advanced Lateral Flow Conference (ALFC), presented by DCN Dx, is the leading global event for ...